Systematic Reviews
Copyright ©The Author(s) 2020.
World J Clin Infect Dis. Jun 18, 2020; 10(2): 24-32
Published online Jun 18, 2020. doi: 10.5495/wjcid.v10.i2.24
Table 1 Characteristics of the studies included
StudyDurationDesignCountryNumberMaleAgeMINORs score
Li et al[11], 2020Jan 2020- Feb 2020RetrospectiveChina834445.514 (Low)
Zhou et al[12], 2020Dec 2019- Jan 2020RetrospectiveChina1911195613 (High)
Liu et al[13], 2020Dec 2019- Jan 2020RetrospectiveChina78393812 (High)
Qu et al[14], 2020Dec 2019- Jan 2020RetrospectiveChina301650.513 (High)
Wu et al[15], 2020Dec 2019- Jan 2020RetrospectiveChina2011285112 (High)
Table 2 Clinical symptoms of the patients, n (%)
StudyFeverCoughDyspneaAbdominalMyalgiaHeadacheCritical cases
Li et al[11], 202072 (86.7)65 (78.3)9 (10.8)7 (8.4)15 (18.1)9 (10.8)25 (30.1)
Zhou et al[12], 2020180 (94.2)151 (79)NA9 (4.7%)29 (15.1)NA119 (62.3)
Liu et al[13], 2020NA34 (34.6)NANANANA11 (14.1)
Qu et al[14], 2020NANANANANANA3 (10)
Wu et al[15], 2020188 (93.5)163 (81.1)80 (39.8)NA65 (32.3)NA84 (41.8)
Table 3 Complications and mortality of coronavirus disease 2019 in the studies
StudyComplicationsARDSMortality
Li et al[11], 20202525NA
Zhou et al[12], 202049316254
Liu et al[13], 202020202
Qu et al[14], 2020NANANA
Wu et al[15], 2020848444
Table 4 Prognostic scoring system to predict severe coronavirus disease 2019
Predictive factorOdds ratioScore points
Bronchial wall thickening in CT scan32.5933
CT score > 719.2002
Elevated D-dimer18.422
Decreased monocyte ratio182
Smoking14.2852
Elevated C-reactive protein13.21
Lymphopenia121
Dyspnea10.8991
Chest pain10.851
Medical comorbidities10.6071